In this study, we optimized an EAIAD mouse model that mimics allergen-driven asthma without traditional adjuvants, to test bio-mimetic nanocarriers co-delivering the OVA antigen and the TLR7/8 agonist 3M-052 on the same nanoparticle. The gene discussed is TLR7; the disease is asthma.